Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a717ea5b2ac78ac329ab3a9659d834d2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-66 |
filingDate |
1987-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1989-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01991c83ab47e72f5a3262d5f92fdcb7 |
publicationDate |
1989-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-4866197-A |
titleOfInvention |
Production of N-((2-alkoxy-6-methoxy-5-(trifluoromethyl)-1-naphthalenyl)carbonyl)-N-methylglycine esters |
abstract |
Process for the production of N-[[2-alkoxy-6-methoxy-5-(trifluoromethyl)-1-naphthalenyl]carbonyl]-N-methylglycine esters and intermediates for their production. Said esters are themselves intermediates for the manufacture of compounds which inhibit aldose reductase and are useful for the treatment of diabetic complications. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2604598-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2604599-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2067776-A1 |
priorityDate |
1987-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |